Shuttle Pharmaceuticals Inc Market Cap ($2.07 Million)
Market Cap & Net Worth: Shuttle Pharmaceuticals Inc (SHPH)
Shuttle Pharmaceuticals Inc market cap. Shuttle Pharmaceuticals Inc (NASDAQ:SHPH) has a market capitalization of $2.07 Million ($2.07 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30012 globally and #6128 in its home market, demonstrating a 1.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shuttle Pharmaceuticals Inc's stock price $4.95 by its total outstanding shares 585129 (585.13K). Also see Shuttle Pharmaceuticals Inc (SHPH) cash conversion ratio for how efficiently the company converts equity into cash flow.
Shuttle Pharmaceuticals Inc Market Cap History (2015–2026)
Shuttle Pharmaceuticals Inc market cap history from 2015 to 2026. Data shows growth from $351.08 to $2.90 Million (134.68% CAGR). Check SHPH share price today for real-time trading data and today's change.
Index Memberships
Shuttle Pharmaceuticals Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.00% | #869 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #2778 of 3165 |
Weight: Shuttle Pharmaceuticals Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Shuttle Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shuttle Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore SHPH net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SHPH by Market Capitalization
Companies near Shuttle Pharmaceuticals Inc in the global market cap rankings as of November 3, 2026. Also see Shuttle Pharmaceuticals Inc (SHPH) total assets for a full breakdown of the balance sheet.
Key companies related to Shuttle Pharmaceuticals Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Shuttle Pharmaceuticals Inc (2015–2026)
Market capitalization of Shuttle Pharmaceuticals Inc from 2015 to today. Between 2015 and today, Shuttle Pharmaceuticals Inc's market cap moved from $351.08 to $ 2.90 Million, with a yearly change of 134.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.90 Million | +175.00% |
| 2025 | $1.05 Million | +109.55% |
| 2024 | $502.63K | -76.40% |
| 2023 | $2.13 Million | -76.79% |
| 2022 | $9.17 Million | +3919900.00% |
| 2017 | $234.05 | -63.64% |
| 2016 | $643.64 | +83.33% |
| 2015 | $351.08 | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Shuttle Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.07 Million USD |
| MoneyControl | $2.07 Million USD |
| MarketWatch | $2.07 Million USD |
| marketcap.company | $2.07 Million USD |
| Reuters | $2.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shuttle Pharmaceuticals Inc
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.